Literature DB >> 28941526

Pediatric Myasthenia Gravis.

Jason H Peragallo1.   

Abstract

Myasthenia gravis is a disorder of neuromuscular transmission that leads to fatigue of skeletal muscles and fluctuating weakness. Myasthenia that affects children can be classified into the following 3 forms: transient neonatal myasthenia, congenital myasthenic syndromes, and juvenile myasthenia gravis (JMG). JMG is an autoimmune disorder that has a tendency to affect the extraocular muscles, but can also affect all skeletal muscles leading to generalized weakness and fatigability. Respiratory muscles may be involved leading to respiratory failure requiring ventilator support. Diagnosis should be suspected clinically, and confirmatory diagnostic testing be performed, including serum acetylcholine receptor antibodies, repetitive nerve stimulation, and electromyography. Treatment for JMG includes acetylcholinesterase inhibitors, immunosuppressive medications, plasma exchange, intravenous immunoglobulins, and thymectomy. Children with myasthenia gravis require monitoring by a pediatric ophthalmologist for the development of amblyopia from ptosis or strabismus.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2017        PMID: 28941526     DOI: 10.1016/j.spen.2017.04.003

Source DB:  PubMed          Journal:  Semin Pediatr Neurol        ISSN: 1071-9091            Impact factor:   1.636


  10 in total

1.  The Dental Management of Pediatric Patient Diagnosed with Myasthenia Gravis: A Case Report.

Authors:  Saad M AlManea; Mashael A AlHadlaq; Noura M AlBuqmi; Sultan S AlGomaiz
Journal:  Eur J Dent       Date:  2022-06-21

2.  [Clinical effect of tacrolimus in the treatment of myasthenia gravis in children].

Authors:  Jiu-Wei Li; Fang Fang; Xiao-Tun Ren; Wei-Hua Zhang; Xin-Ying Yang; Chang-Hong Ren; Shuai Gong; Jun-Lan Lyu; Xiao-Hui Wang; Xu Wang; Hu-Sheng Wu; Chang-Hong Ding
Journal:  Zhongguo Dang Dai Er Ke Za Zhi       Date:  2020-09

3.  An ocular myasthenia gravis attack after oral pyrantel pamoate: An unusual case report.

Authors:  Chaolan Shen; Min Li; Xin Zhao; Lin Cui
Journal:  Medicine (Baltimore)       Date:  2019-07       Impact factor: 1.817

4.  Myasthenia Gravis Masquerading as Status Asthmaticus.

Authors:  Neha Pirwani; Shayna Wrublik; Shashikanth Ambati
Journal:  Case Rep Pediatr       Date:  2021-12-28

5.  New-Onset Ocular Myasthenia after Multisystem Inflammatory Syndrome in Children.

Authors:  Pınar Yavuz; Osman Oguz Demir; Yasemin Ozsurekci; Seza Ozen; Banu Anlar; Goknur Haliloglu
Journal:  J Pediatr       Date:  2022-02-26       Impact factor: 6.314

6.  Alopecia and colon ulcers following azathioprine use in a patient with myasthenia gravis: A case report.

Authors:  Wan-Yi Hsu; Pei-Chin Lin; Yi-Ching Liu; Lung-Chang Lin
Journal:  Medicine (Baltimore)       Date:  2022-08-19       Impact factor: 1.817

7.  MiR-522-3p inhibits proliferation and activation by regulating the expression of SLC31A1 in T cells.

Authors:  Hengxiao Lu; Hao Wang; Peidao Sun; Jiang Wang; Shuhai Li; Tongzhen Xu
Journal:  Cytotechnology       Date:  2021-05-07       Impact factor: 2.040

Review 8.  S1P/S1P Receptor Signaling in Neuromuscolar Disorders.

Authors:  Elisabetta Meacci; Mercedes Garcia-Gil
Journal:  Int J Mol Sci       Date:  2019-12-17       Impact factor: 5.923

Review 9.  Fc-Receptor Targeted Therapies for the Treatment of Myasthenia gravis.

Authors:  Christian W Keller; Marc Pawlitzki; Heinz Wiendl; Jan D Lünemann
Journal:  Int J Mol Sci       Date:  2021-05-28       Impact factor: 5.923

10.  Transient Neonatal Myasthenia Gravis: A Case Report.

Authors:  Catarina Santiago Gonçalves; M Ines Nunes Marques; Sónia Antunes; Ana Serrano
Journal:  Cureus       Date:  2021-12-22
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.